Liberia

in page functions
[French]
Liberia
Total population (2017) 4,730,436
Birth cohort (2017) 160,474
Surviving Infants (surviving to 1 year per year, 2017) 151,948
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 53/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 70/1000
World Bank Index, IDA (2015) 3.10
Gross Nation Income (per capita US$, 2015) 380
Co-financing group (2017) Initial self-financing
No. of districts/territories (2015) 15

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Liberia

Type of support

Approvals

2001-2021 (US$)
(23 May 2017)

Commitments

2001-2021 (US$)
(23 May 2017)

Disbursements

2000-2017 (US$)
(23 May 2017)

% Disbursed

(23 May 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $34,960,067 $46,186,067 $36,836,458
Cash Support (CASHSUPP) $198,500 $223,500 $198,500 100%
Ebola EPI Recovery Plan (EEPIRP) $2,811,269 $2,811,269 $2,811,269 100%
Health system strengthening (HSS 1) $3,689,254 $3,689,254 $3,689,254 100%
Health system strengthening (HSS 2) $3,240,000 $3,240,000 $3,240,000 100%
HPV Demo (NVS) $299,607 $299,607 $234,348 78%
Immunisation services support (ISS) $2,188,750 $2,188,750 $2,188,750 100%
Injection Safety Devices (NVS) $51,500 $246,000 $63,362 123%
Injection safety support (INS) $360,500 $360,500 $266,500 74%
IPV (NVS) $70,910 $70,910 $13,068 18%
Penta (NVS) $10,700,808 $13,261,808 $11,448,794 107%
Pneumo (NVS) $7,014,720 $12,712,720 $8,306,840 118%
Rotavirus (NVS) $1,628,941 $3,807,941 $1,596,852 98%
Vaccine Introduction Grant (VIG) $619,000 $619,000 $619,000 100%
Yellow Fever (NVS) $2,086,308 $2,654,808 $2,159,921 104%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Liberia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 65%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2012) 69.20%
Household survey: DTP3 coverage for female (2012) 73.80%
Household survey: Last DTP3 survey (2012) 71%
% districts achieving > 80% DTP3 coverage (2015) 20%
% districts achieving < 50% DTP3 coverage (2015) 7%
MCV WHO/UNICEF estimates (2015) 64%

Breakdown of support

Non-vaccine support Vaccine support
35% 65%
$13,013,273 $23,823,185

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Liberia

23 May 2017

Seth Q&A 1

The Best Intervention: Gavi CEO Seth Berkley's Q&A, Part I

Ahead of Seth Berkley’s speech to the 2017 graduating class at Johns Hopkins University in Washington, DC on 23 June, Global Health published a two-part Q&A with the Gavi CEO. In this first article, Seth describes Gavi’s latest priorities, highlights the increased risk of epidemics starting in densely populated urban slums and emphasises the need to reach every child with all WHO-recommended vaccines.

12 May 2017

Ebola

Gavi stands ready to support the DR Congo in its fight against Ebola

Gavi statement of support follows official confirmation of Ebola outbreak in the Democratic Republic of the Congo (DRC).

02 November 2016

liberia-girls-HPV-vaccination-card

New Lancet figures show vaccine could save 600,000 women's lives from cervical cancer

Study warns that without urgent action cases could rise by 25% by 2030.

close icon

modal window here